CureDuchenne Ventures Invests $5 Million in Duchenne Gene Therapy – Rare Disease Report
Rare Disease Report |
CureDuchenne Ventures Invests $5 Million in Duchenne Gene Therapy
Rare Disease Report In a press release, Dr. Olsen said, “This represents the next generation of potential Duchenne muscular dystrophy therapies. By leveraging the revolutionary CRISPR/Cas9 method to permanently correct errors in the DNA sequence, it is our hope that we … Nonprofit Seeds Exonics to Fund Push For CRISPR Duchenne Treatment CureDuchenne Ventures Invests in New Gene Editing Company Exonics Therapeutics to Advance CRISPR/Cas9 … Exonics to use CRISPR in an effort to treat majority of DMD boys |
